Drug interactions: Who warns the patient.
出版信息
CMAJ. 1999 Jul 27;161(2):117.
Abstract
摘要
相似文献
1
Drug interactions: Who warns the patient.
CMAJ. 1999 Jul 27;161(2):117.
2
Seldane warnings.
Posit Aware. 1997 Nov-Dec;8(6):12.
3
Seldane approval may be withdrawn by FDA.
AIDS Patient Care STDS. 1997 Jun;11(3):197-8.
4
Newer antihistamines.
Med Lett Drugs Ther. 2001 Apr 30;43(1103):35.
5
Are herbal products dietary supplements or drugs? An important question for public safety.
Clin Pharmacol Ther. 2002 Jun;71(6):411-3. doi: 10.1067/mcp.2002.125975.
6
Fexofenadine hydrochloride--a new anti-histaminic drug.
Isr Med Assoc J. 2001 Mar;3(3):207-9.
7
Cetirizine.
Nurs Times. 2005;101(19):55.
8
[Effect of fexofenadine--selective antagonist of histamine receptor (H1) on histamine-induced bronchoconstriction].
Pol Merkur Lekarski. 2003 Jan;14(79):43-6.
9
[Olopatadine].
Rev Infirm. 2004 Apr(100):43-4.
10
[Adverse effects of H1-receptor antagonists].
Nihon Rinsho. 2007 Oct 28;65 Suppl 8:267-71.
引用本文的文献
1
Lessons from cisapride.
CMAJ. 2001 May 1;164(9):1269, 1271.
Zotero 插件